“…Thus, siderol has great potential to be exploited as a potent anticancer agent, and its derivatization or formulation should be considered in order to enhance even more its cytotoxic efficacy. In order to evaluate the potential similarity of the isolated chemotype of siderol with other compounds with known bioactivity in the CHEMBL database, we conducted a 3D-based virtual screening [36]. The highest hits, going from the highest-ranking to the lowest, were compounds (4aS,6S,6aS,8S,9R,11aS,11bS)-8-hydroxy-4,4,9,11b-tetramethyltetradecahydro-9,11a-methanocyclohepta [a]naphthalen-6-yl acetate (CHEMBL494391), (4aS,4bR,8R,8aR,9R,10aR)-8-(hydroxymethyl)-1,4b,8trimethyl-2-vinyl-3,4,4a,4b,5,6,7,8,8a,9,10,10a-dodecahydrophenanthren-9-yl acetate (CHEMBL482794), (4aR,5S,6aS,7R,9R,11bR)-5-hydroxy-4,4,11b-trimethyl-8-methylene-1,2,3,4,4a,5,6,7,8,9,10,11b-dodecahydro-6a,9-methanocyclohepta[a]naphthalen-7-yl acetate (CHEMBL448113), ((1R,4aS,4bR,7S,8aS,10aR)-8a-hydroxy-1,4a,7-trimethyl-7-vinyltetradecahydrophenanthren-1-yl)methyl acetate (CHEMBL509521), and ethyl (4R,4aS,6aR,9S,11aR,11bS)-4,9,11b-trimethyl-8-oxotetradecahydro-6a,9-methanocyclohepta[a] naphthalene-4-carboxylate (CHEMBL455441).…”